Comparative cost-effectiveness of focal and total salvage 125 I brachytherapy for recurrent prostate cancer after primary radiotherapy
Purpose: Focal salvage (FS) iodine 125 ( 125 I) brachytherapy could be an effective treatment for locally radiorecurrent prostate cancer (PCa). Toxicity is often reduced compared to total salvage (TS) while cancer control can be maintained, which could increase cost-effectiveness. The current study...
Main Authors: | Max Peters, Marjanne A. Piena, Lotte M.G. Steuten, Jochem R.N. van der Voort van Zyp, Marinus A. Moerland, Marco van Vulpen |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-12-01
|
Series: | Journal of Contemporary Brachytherapy |
Subjects: | |
Online Access: | https://www.termedia.pl/Comparative-cost-effectiveness-of-focal-and-total-salvage-125-I-brachytherapy-for-recurrent-prostate-cancer-after-primary-radiotherapy,54,28974,1,1.html |
Similar Items
-
CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
by: Hong Dong, et al.
Published: (2021-05-01) -
Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
by: Metha Maenhout, et al.
Published: (2017-04-01) -
Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
by: Thomas Willigenburg, et al.
Published: (2021-09-01) -
Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
by: Menachem Z. Yondorf, et al.
Published: (2020-08-01) -
Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study
by: Thomas Willigenburg, et al.
Published: (2020-07-01)